Supporting Information

Slides:



Advertisements
Similar presentations
Preparation of competent E. coli cells Preparation of probes by PCR Digestion of pBR322 and plasmid with restrionenzymes BamH1, EcoR1 and EcoRV Purification.
Advertisements

Epigenetics Lab December 1, 2008 Goals of today’s lab: 1.Understand the basic molecular techniques used in the lab to study epigenetic silencing in cancer.
Revision – Concept map.
Trends Biomedical Science
Date of download: 9/19/2016 Copyright © 2016 American Medical Association. All rights reserved. From: Germline Epigenetic Regulation of KILLIN in Cowden.
Volume 46, Issue 6, Pages (December 2004)
Xiang Qian, Long Jin, Elzbieta Kulig, Ricardo V. Lloyd 
Figure S3. Absence of DNA methylation in pre-cancerous thymocytes
Imprinting-Mutation Mechanisms in Prader-Willi Syndrome
Volume 6, Issue 4, Pages (October 2000)
Volume 18, Issue 2, Pages (February 2010)
Induction of Pluripotent Stem Cells from Mouse Embryonic and Adult Fibroblast Cultures by Defined Factors  Kazutoshi Takahashi, Shinya Yamanaka  Cell 
Table S1. Characterization of CpG Islands Methylated in Lymphomas
Promoter-Specific Hypomethylation Is Associated with Overexpression of PLS3, GATA6, and TWIST1 in the Sezary Syndrome  Henry K. Wong, Heather Gibson,
Volume 69, Issue 6, Pages (March 2006)
TSC-22 contributes to hematopoietic precursor cell proliferation and repopulation and is epigenetically silenced in large granular lymphocyte leukemia.
Volume 136, Issue 2, Pages e1 (February 2009)
The Mre11 Complex Is Required for Repair of Hairpin-Capped Double-Strand Breaks and Prevention of Chromosome Rearrangements  Kirill S. Lobachev, Dmitry.
Isothermal Multiple Displacement Amplification
Volume 116, Issue 2, Pages (February 1999)
Epigenetic Inhibition of Nuclear Receptor Small Heterodimer Partner Is Associated With and Regulates Hepatocellular Carcinoma Growth  Nan He, Kyungtae.
Detection of Aberrant TERT Promoter Methylation by Combined Bisulfite Restriction Enzyme Analysis for Cancer Diagnosis  Seungjae Lee, Sumit Borah, Armita.
Discordance between Genetic and Epigenetic Defects in Pseudohypoparathyroidism Type 1b Revealed by Inconsistent Loss of Maternal Imprinting at GNAS1 
Volume 15, Issue 6, Pages (May 2016)
Volume 10, Issue 1, Pages (July 2002)
Addition of H19 ‘Loss of Methylation Testing’ for Beckwith-Wiedemann Syndrome (BWS) Increases the Diagnostic Yield  Jochen K. Lennerz, Robert J. Timmerman,
CpG Methylation of a Plasmid Vector Results in Extended Transgene Product Expression by Circumventing Induction of Immune Responses  A. Reyes-Sandoval,
Volume 2, Issue 4, Pages (October 1998)
Volume 29, Issue 1, Pages (April 2014)
Claire Soudais, Sylvie Boutin, Eric J. Kremer  Molecular Therapy 
GATA2 is Epigenetically Repressed in Human and Mouse Lung Tumors and Is Not Requisite for Survival of KRAS Mutant Lung Cancer  Mathewos Tessema, PhD,
Volume 2, Issue 4, Pages (October 2000)
Volume 133, Issue 6, Pages (December 2007)
Inhibition of DNA Methylation in the COL1A2 Promoter by Anacardic Acid Prevents UV- Induced Decrease of Type I Procollagen Expression  Min-Kyoung Kim,
Chun Feng, M. D. , Shen Tian, Ph. D. , Yu Zhang, M. D. , Jing He, M. D
Developmentally Programmed Rearrangement of T Cell Receptor Vγ Genes Is Controlled by Sequences Immediately Upstream of the Vγ Genes  Jeanne E Baker,
Xiaofeng Cao, Steven E. Jacobsen  Current Biology 
Differential DNA Methylation as a Tool for Noninvasive Prenatal Diagnosis (NIPD) of X Chromosome Aneuploidies  Floriana Della Ragione, Paola Mastrovito,
Volume 4, Issue 5, Pages (November 2003)
Volume 124, Issue 3, Pages (March 2003)
RASSF10 Promoter Hypermethylation Is Frequent in Malignant Melanoma of the Skin but Uncommon in Nevus Cell Nevi  Peter Helmbold, Antje M. Richter, Sara.
Volume 12, Issue 6, Pages (December 2010)
S. Hussain Askree, Shika Dharamrup, Lawrence N. Hjelm, Bradford Coffee 
Volume 11, Issue 19, Pages (October 2001)
Syed Hussain Askree, Lawrence N
Hypermethylation of estrogen receptor-α gene in atheromatosis patients and its correlation with homocysteine  Yu-Shan Huang, Yan-Fang Zhi, Shu-Ren Wang 
Volume 18, Issue 2, Pages (February 2010)
Hypermethylation of the CpG Island Near the G4C2 Repeat in ALS with a C9orf72 Expansion  Zhengrui Xi, Lorne Zinman, Danielle Moreno, Jennifer Schymick,
Volume 132, Issue 4, Pages (April 2007)
Methylation of PTEN as a Prognostic Factor in Malignant Melanoma of the Skin  Christoph Lahtz, René Stranzenbach, Eckhard Fiedler, Peter Helmbold, Reinhard.
Volume 12, Issue 5, Pages (November 2007)
A Physical Map, Including a BAC/PAC Clone Contig, of the Williams-Beuren Syndrome– Deletion Region at 7q11.23  Risa Peoples, Yvonne Franke, Yu-Ker Wang,
Volume 13, Issue 24, Pages (December 2003)
Amplification and Overexpression of the EMS 1 Oncogene, a Possible Prognostic Marker, in Human Hepatocellular Carcinoma  Bao-Zhu Yuan, Xiaoling Zhou,
Volume 17, Issue 1, Pages (January 2007)
Β-globin Gene Switching and DNase I Sensitivity of the Endogenous β-globin Locus in Mice Do Not Require the Locus Control Region  M.A Bender, Michael.
The human GPR109A promoter is methylated and GPR109A expression is silenced in human colon carcinoma cells. The human GPR109A promoter is methylated and.
APOE Gene Targeting (A) Schematic representation of the endogenous APOE locus, the gene targeting vector and the targeted APOE locus. The exons of the.
Volume 124, Issue 5, Pages (May 2003)
Xing-Wei Liang, Ph. D. , Zhao-Jia Ge, M. S. , Lei Guo, Ph. D
B. Bakhshi, M.R. Pourshafie, F. Navabakbar, A. Tavakoli 
Assessing the Functional Characteristics of Synonymous and Nonsynonymous Mutation Candidates by Use of Large DNA Constructs  A.M. Eeds, D. Mortlock, R.
Volume 10, Issue 5, Pages (November 2002)
Association of In Vitro Fertilization with Beckwith-Wiedemann Syndrome and Epigenetic Alterations of LIT1 and H19  Michael R. DeBaun, Emily L. Niemitz,
Volume 17, Issue 1, Pages (January 2009)
Gli1 Protein is Expressed in Basal Cell Carcinomas, Outer Root Sheath Keratinocytes and a Subpopulation of Mesenchymal Cells in Normal Human Skin  Lucy.
Methylation status of IGFBPL1 in human breast cancer.
Bradford Coffee, Fuping Zhang, Stephanie Ceman, Stephen T
Volume 13, Issue 1, Pages (January 2006)
K. Miura, M. Obama, K. Yun, H. Masuzaki, Y. Ikeda, S. Yoshimura, T
Presentation transcript:

Supporting Information CpG Island Methylation in Lymphoma Is Driven by the Genetic Configuration of Tumor Cells Rene Opavsky, Shu-Huei Wang, Prashant Trikha, Aparna Raval, Yuan Huang, Yue-Zhong Wu, Benjamin Rodriguez, Benjamin Keller, Sandya Liyanarachi, Guo Wei, Ramana V. Davuluri, Michael Weinstein, Dean Felsher, Michael Ostrowski, Gustavo Leone and Christoph Plass Figure S1. Methylation and Expression of RLGS Sequences (A) Southern blot analysis of control and tumor cell DNAs using RLGS fragments 6D20, 1F21 and 3F56 as probes. Control DNA (con) or Tumor DNAs (tumor) isolated from thymocytes of healthy EμSR-tTA mice or T cell lymphomas, respectively was digested either with EcoRV alone (-) or with EcoRV and NotI (+). The top bands (M) indicate methylated (not digested with NotI) and the lower bands indicate fragments digested with NotI (U). (B) Combined bisulfite restriction analysis (COBRA) analysis of bisulfite-treated DNA isolated from thymocytes of EμSR-tTA mice (con) or from nine different T cell lymphomas (tumors). PCR products were digested with restriction enzyme BstUI and loaded on PAGE gel along with 100 bp marker (M) and 100 % methylated (SssI treated DNA) control (100%). Undigested and digested fragments correspond to unmethylated and methylated DNA, respectively. (C) Expression of genes near the RLGS fragments 6D20, 5D36 and 3F70 was quantified in thymocytes isolated from three EμSR-tTA mice (open bars) and eight EμSR-tTA;Teto-MYC tumors (black bars) using real-time RT-PCR. The y-axis represents fold-decrease in gene expression relative to the levels of gene expression detected in the first control.

D A B C Figure S1 3F56 1F21 6D20 2G50 2F37 4E58 6D20 5D36 3F70 tumors con - + + + + + + + + + - M - U - + + + + + + + + + + 1F21 6D20 - + + + + + + + + + B 100% 2G50 2F37 M 4E58 con tumors undigest. fragment digest. fragments C D 6D20 5D36 3F70 tumors con 1 2 3 1 2 3 4 5 6 7 8 1 2 3 1 2 3 4 5 6 7 8 9 in gene expression Fold reduction 20 40 60 80 10 30 50 100 Figure S1